文献速递间质性肺疾病

经支气管冷冻活检按需联合外科肺活检与立即外科肺活检诊断间质性肺病:COLD随机对照试验

Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial.
PubMed 文献 · Lancet Respir Med · 2024-04-16

COLD研究为荷兰六家医院的多中心随机对照试验,纳入需肺活检的间质性肺病患者55例,比较先经支气管冷冻活检、结果不充分时再行外科肺活检的阶梯策略与立即外科肺活检。阶梯策略意外胸管引流更少、住院时间更短、严重不良事件更少,而多学科团队诊断率相近。

要点

  • 阶梯策略意外胸管引流11%,立即外科肺活检组胸管24小时内无法拔除46%,绝对风险降低35%。
  • 阶梯策略冷冻活检 alone 诊断率82%,补充外科肺活检后89%;立即外科肺活检组88%。
  • 阶梯策略住院1天、严重不良事件4%;立即外科肺活检住院5天、严重不良事件50%。

核心结论

  • 需肺组织评估的间质性肺病患者,先经支气管冷冻活检、结果不充分时再行外科肺活检的阶梯策略,较立即外科肺活检显著降低患者负担和住院时间,诊断率相近。

研究设计与样本

  • COLD研究为多中心随机对照试验,在荷兰六家医院开展,纳入多学科团队讨论认为需肺活检的间质性肺病患者。
  • 55例患者按1:1随机分入阶梯策略组(n=28)或立即外科肺活检组(n=27),随访12周,采用改良意向性分析。
  • 主要终点为意外胸管引流,即冷冻活检后需任何胸管或外科肺活检后胸管引流延长(>24小时)。

主要发现

  • 阶梯策略组单纯冷冻活检后多学科团队诊断率为82%(64-92%),冷冻活检结果不明确后补充外科肺活检升至89%(73-96%);立即外科肺活检组为88%(69-97%)。
  • 总住院时间阶梯策略组为1天(IQR 1-1),立即外科肺活检组为5天(IQR 4-6)。
  • 严重不良事件阶梯策略组1例(4%),立即外科肺活检组12例(50%)。

临床怎么用

  • 对多学科团队讨论认为需肺活检的间质性肺病患者,可优先采用经支气管冷冻活检,结果不充分时再行外科肺活检。

局限性

  • 患者、临床医生和病理医生未对研究分组设盲。
  • 研究样本量较小,共55例随机分组,立即外科肺活检组3例被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An adequate diagnosis for interstitial lung disease (ILD) is important for clinical decision making and prognosis. In most patients with ILD, an accurate diagnosis can be made by clinical and radiological data assessment, but in a considerable proportion of patients, a lung biopsy is required. Surgical lung biopsy (SLB) is the most common method to obtain tissue, but it is associated with high morbidity and even mortality. More recently, transbronchial cryobiopsy has been introduced, with fewer adverse events but a lower diagnostic yield than SLB. The aim of this study is to compare two diagnostic strategies: a step-up strategy (transbronchial cryobiopsy, followed by SLB if the cryobiopsy is insufficiently informative) versus immediate SLB. METHODS: The COLD study was a multicentre, randomised controlled trial in six hospitals across the Netherlands. We included patients with ILD with an indication for lung biopsy as assessed by a multidisciplinary team discussion. Patients were randomly assigned in a 1:1 ratio to the step-up or immediate SLB strategy, with follow-up for 12 weeks from the initial procedure. Patients, clinicians, and pathologists were not masked to the study treatment. The primary endpoint was unexpected chest tube drainage, defined as requiring any chest tube after transbronchial cryobiopsy, or prolonged (>24 h) chest tube drainage after SLB. Secondary endpoints were diagnostic yield, in-hospital stay, pain, and serious adverse events. A modified intention-to-treat analysis was performed. This trial is registered with the Dutch Trial Register, NL7634, and is now closed. FINDINGS: Between April 8, 2019, and Oct 24, 2021, 122 patients with ILD were assessed for study participation; and 55 patients were randomly assigned to the step-up strategy (n=28) or immediate SLB (n=27); three patients from the immediate SLB group were excluded. Unexpected chest tube drainage occurred in three of 28 patients (11%; 95% CI 4-27%) in the step-up group, and the number of patients for whom the chest tube could not be removed within 24 h was 11 of 24 patients (46%; 95% CI 2-65%) in the SLB group, with an absolute risk reduction of 35% (11-56%; p=0·0058). In the step-up strategy, the multidisciplinary team diagnostic yield after transbronchial cryobiopsy alone was 82% (64-92%), which increased to 89% (73-96%) when subsequent SLB was performed after inconclusive transbronchial cryobiopsy. In the immediate surgery strategy, the multidisciplinary team diagnostic yield was 88% (69-97%). Total in-hospital stay was 1 day (IQR 1-1) in the step-up group versus 5 days (IQR 4-6) in the SLB group. One (4%) serious adverse event occurred in step-up strategy versus 12 (50%) in the immediate SLB strategy. INTERPRETATION: In ILD diagnosis, if lung tissue assessment is required, a diagnostic strategy starting with transbronchial cryobiopsy, followed by SLB when transbronchial cryobiopsy is inconclusive, appears to result in a significant reduction of patient burden and in-hospital stay with a similar diagnostic yield versus immediate SLB. FUNDING: Netherlands Organisation for Health Research and Development (ZonMW) and Amsterdam University Medical Centers.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Kalverda KA, Ninaber MK, Wijmans L, et al. Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial. Lancet Respir Med. 2024. PMID: 38640934. doi:10.1016/S2213-2600(24)00074-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。